Chengguan District, Lanzhou, Gansu, China sales01@liwei-chem.com 1557459043@qq.com
Follow us:



Lactose BP EP USP Pharma Grade: A Deep Dive into a Pharmaceutical Staple

Historical Development

Lactose kicks off its story centuries ago, as early pharmacists noticed its unique sweetness and gentle texture. Originally recognized as a milk sugar in the early 1600s, lactose gained traction in pharmaceutical manufacturing once Europe’s chemists managed to isolate its crystals in the late 18th century. By the 20th century, global demand grew with industrial-scale dairy production and the expanding need for reliable tablet fillers. Regulatory standards upped the stakes, pushing refiners to meet benchmarks set by pharmacopeias like BP, EP, and USP. Hospitals, research labs, and drug manufacturers today all trust this ingredient, not just for tradition’s sake but because generations of scientists, regulators, and industry tinkering have proven lactose keeps drugs safe and stable.

Product Overview

You’ll spot pharmaceutical-grade lactose everywhere — from white powders in tablet bottles to fillers in tiny capsules. Its heritage comes from milk, often cow’s milk, but the refining processes leave behind any proteins or fats, isolating this single sugar. BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) versions all aim for top-level purity and batch-to-batch consistency. Producers check for yeast, mold, and heavy metals, knowing these contaminants could compromise medicine quality. Drug makers turn to lactose because it handles well during mixing, slides easily into tablet presses, and adds no strange tastes or smells. People like me have spent years in quality control, scrupulously measuring samples to guarantee products hit benchmarks outlined by different pharmacopeias. It’s trust built one analytical result at a time.

Physical & Chemical Properties

Lactose stands out with its white, pretty-much tasteless crystals. It comes in two main forms, alpha-lactose monohydrate and anhydrous lactose. Alpha-lactose tends to hold a bit of water and packs denser, while the anhydrous form proves handy if you need something that won’t soak up moisture from the air. Lactose weighs in at a molecular formula of C12H22O11 and a molar mass of about 342.3 g/mol. It dissolves nicely in water, which makes it great for oral medicines that need to release their contents quickly, but struggles with most organic solvents. Its mild sweetness, about one-sixth of table sugar, means people rarely notice it in medicines. Years spent working with formulation scientists showed me that its consistent flow characteristics and softness allow for smoother tablet production, avoiding machine jams or inconsistent fill weights.

Technical Specifications & Labeling

Pharmaceutical lactose doesn’t get by with vague labels or slapdash specs. Industry buyers drill down into the nitty-gritty — testing for loss on drying, verifying microbiological counts, and measuring bulk density to avoid surprises on the production line. Labels spell out mesh size, hydration status, and source, since regulators want to trace everything. Manufacturers identify each lot by number, manufacturing date, and compliance with monographs from BP, EP, or USP as applicable. Shelf-life and storage demands show up clearly since lactose can clump or degrade if stored in humidity. Mistakes here don’t just hit the producer — whole batches of medication may fail, causing reputational and financial pain. As someone who’s handled audits, missing a spec on lactose can bring a busy production floor to a halt.

Preparation Method

Early days of lactose production looked nothing like today’s industrial plants. Farmers started by letting milk sour, then skimming off whey and letting crystals form. Now, companies filter, ultra-centrifuge, pasteurize, and spray-dry whey to collect and purify the lactose. Enormous stainless steel columns and clean rooms guarantee pharmaceutical grade, stripping away contaminants and concentrating the sugar. Purification often relies on multiple crystallizations under controlled conditions. Final drying steps suck out water, set particle size, and shape the crystal structure to fit whatever use pharmaceutical companies demand. These steps need regular monitoring—our teams run constant checks for protein, microbial, and heavy metal contamination throughout production. Ultimately, these rigorous processes help meet tight standards demanded by regulators and end users alike.

Chemical Reactions & Modifications

Lactose doesn’t just fill space in a tablet. Under the right circumstances, it can undergo breakdown or modification, especially with heat, acid, or enzymes. In fact, digestive enzyme lactase snaps lactose into glucose and galactose, which makes it digestible for most people, except those with intolerance due to low lactase levels. Acid hydrolysis or other chemical tweaks produce derivatives such as lactulose, which finds uses for treating constipation. In my lab days, we tracked Maillard reactions — that browning you see — which can happen in poorly stored lactose, sometimes affecting drug stability if overlooked. Chemical engineers constantly hunt for ways to prevent unwanted changes, tweaking formulations to cut risks. Even a slight tweak in humidity or temperature control during storage or shipping can tip the balance, making this a critical part of pharmaceutical design.

Synonyms & Product Names

Pharma circles can toss around a half dozen names for this staple. Some call it “milk sugar,” though scientists prefer “lactose monohydrate” or “anhydrous lactose.” BP, EP, and USP labels often add their own codes and designations, along with commercial brands that boast tiny differences in purity or granule size. In my direct work with suppliers, branded pharma lactose came with detailed disclaimers and supporting data sheets, so no two buyers got the same product presentation. Sometimes buyers search for product using legacy names or even just call up suppliers looking for “compressed lactose” without specifying. It pays to check—labels, spec sheets, and certificates of analysis tell you what’s really in the bag.

Safety & Operational Standards

I’ve watched safety protocols evolve over the years. Pharma factories rely on HEPA-filtered rooms, strict gowning, and block contamination at every step. Safety data sheets warn users that lactose dust, if mishandled, can cause mild respiratory irritation—not dangerous for most, but enough for good ventilation and mask policies. Since some batches may still contain minute proteins, labs check for allergenic residues, especially with increasing lactose intolerance diagnoses. Good Manufacturing Practice (GMP) guidelines keep everything clean and monitored, with regular audits and traceability from dairy farm to finished pharma. Handling protocols also require careful waste disposal and environmental considerations, given growing emphasis on sustainability in the industry.

Application Area

Lactose, in pharma-grade form, pops up in more than just oral drug tablets. It acts as a bulking agent, carrier for inhalable powders, and even as a cryoprotectant in certain vaccines. The rise of dry powder inhalers in the treatment of asthma and chronic respiratory diseases depends on lactose to distribute exact doses of drug deep into the lungs. Thousands of pill formulations count on it showing up with a mild taste, non-reactivity, and clean compressibility. Doctors and patients rarely notice it, but without consistent supply and strict quality controls, shelves would sit empty, and drugs would lose effectiveness. My time helping engineers reformulate a controlled-release tablet proved just how tough it can get: swapping out lactose for anything else often means weeks of failed trials and unplanned troubleshooting.

Research & Development

Behind each box of tablets lies years of research. Scientists seek better excipients—yet lactose keeps drawing repeat business. Laboratories fine-tune particle size and hydration to improve drug bioavailability or address allergens for sensitive populations. There’s growing effort to replace dairy sources with engineered or synthetic alternatives to dodge allergy threats or stress on livestock. My conversations with R&D teams highlight the balance labs walk: innovative enough to solve lingering problems, careful enough not to upend well-tested drug formulas. Advanced analytics, such as HPLC or mass spectrometry, are now standard, keeping track of even trace impurities. The relentless focus in R&D departments shows just how high the bar gets for an ingredient so fundamental.

Toxicity Research

Lactose generally earns a “safe” profile, but every new batch draws scrutiny. Toxicologists test for signs of gut irritation, allergies, and uncommon impurities. Studies show most adults tolerate lactose well in medicinal doses, unless they suffer from enzyme deficiencies, in which case even residual traces can trigger discomfort. Chronic exposure brings up questions of cumulative effects, especially for elderly or immunocompromised patients. In my regulatory review work, requests for animal and clinical data became more common, reflecting tighter requirements from global agencies. Risk assessment teams also scan for anything leaching from packaging or shipping materials, a frequently overlooked but increasingly critical concern.

Future Prospects

Demand for pharma-grade lactose will shift, but isn’t vanishing soon. Tightening rules on animal-derived excipients and rising intolerance among populations spark active research into bio-identical and plant-based alternatives. Some companies already invest in microbe-engineered lactose, aiming to sidestep both dairy and purity issues. Expansion of biopharmaceuticals and personalized medicine could force new uses—or drive suppliers to tweak old formulas even further. Artificial intelligence, advanced manufacturing monitoring, and automation promise to further cut contamination risks and increase traceability. Having lived through multiple regulatory changes, I see greater emphasis landing on not only absolute purity, but also environmental impact and full-supply-chain oversight. Pharmaceutical lactose, old as it is, faces more scrutiny and change than ever before—those who stay nimble and creative will set the next benchmarks in safe, reliable therapies.




What is Lactose BP EP USP Pharma Grade used for?

Understanding Its Role

Walk into any pharmacy, pick up a bottle of tablets, and chances are you’ll find lactose in the list of ingredients. Drug manufacturers lean on lactose BP EP USP pharma grade for more than just its availability. This white powder, made from cow’s milk, plays a central role in the world of medications, especially tablets and capsules. Its reputation comes from being safe, cheap, and easy to work with—three qualities that sound simple, yet take years of refinement to guarantee.

Why This Grade?

Not all lactose is created equal. BP, EP, and USP refer to the British Pharmacopoeia, European Pharmacopoeia, and United States Pharmacopeia, which means the lactose has passed tight regulations for pharmaceutical use. Any shortcut during filtration or processing, and the powder could carry risks—think impurities or bacteria that don’t belong in anything we swallow. We rely on this grade because it means someone has done the hard work of checking and certifying each batch for quality and consistency.

Helping Tablets Work

Putting a drug into tablet form takes some real skill. Medicines use only a pinch of active ingredient; the rest is what holds it together and stops it crumbling in your hands. Lactose acts as the backbone. It keeps tablets solid, makes them taste a bit less bitter, and helps them dissolve once swallowed. Chemists trust it because it’s easy to compress and breaks apart in the body without hiccups.

Smooth Delivery Every Time

Some active ingredients in medicine barely fill a thimble—impossible to press into a standard-size tablet on their own. Lactose bulks up the formula, lets machines form pills that look uniform, and keeps the medicine spread out evenly. It mixes without fuss and doesn't change the medicine’s effect, which is exactly what you want in health care. With the correct grade, everyone from the technician in the factory to the nurse giving out a dose can expect reliable results.

Allergy Concerns and Alternatives

With all the good, there’s still a catch: not everyone can digest lactose. People with lactose intolerance might worry about taking it in their medicine. Most tablets have such tiny amounts that even sensitive patients don’t notice side effects, but doctors and pharmacists pay close attention, especially if someone reacts strongly even to traces. For these patients, companies have developed lactose-free fillers like microcrystalline cellulose. As science keeps moving, the industry continues to search for better options for everyone.

Maintaining Trust in Pharma Supplies

Quality in pharmaceuticals is something I never take for granted. Each time a drug gets produced, regulators run regular checks to make sure every ingredient matches strict global standards like those set by BP, EP, and USP. Stories from industry friends tell me it’s not just paperwork—labs run tests for bacteria, heavy metals, and any mistake in the labeling. The process builds trust, not just with doctors but with all of us taking medicine, knowing that every ingredient, right down to a filler like lactose, looks out for our safety.

Looking Forward

Pharma grade lactose has shaped the way we take medicine across the world. As demand for safer and cleaner drugs grows, so does the call for even tighter standards and more allergen-free options. Medical science already pushes for more transparent sourcing and clearer labeling, future-proofing against mistakes and giving patients more control over what they use. It’s a reminder that something as familiar as milk sugar can play a quiet but essential role in keeping us healthy.

Is Lactose BP EP USP Pharma Grade suitable for pharmaceutical formulations?

Understanding the Role of Pharmaceutical-Grade Lactose

Lactose in its pharma grade forms—labeled BP, EP, USP—shows up everywhere in tablets and capsules. As someone with hands-on experience in formulation labs, I’ve seen teams turn to lactose for practical reasons, not just tradition. Its compatibility with a wide range of active ingredients lets it act as a reliable bulking agent. Tablets need a certain size and hardness to work for patients; lactose contributes both. Tablets pressed with pharma-grade lactose break into fine powder just by rubbing them between fingers. This property matters a lot during blending and tableting, because a poor flow can slow down production or result in uneven dosing.

Why Grade Designations Really Matter

Manufacturers slap BP, EP, USP on their lactose, but these aren't fancy stickers—they’re real international standards. I’ve personally dealt with audit teams who comb through ingredient paperwork. If lactose meets these specs, you know impurities like heavy metals or microbial counts fall below strict limits. Years ago, working through a product recall sparked by unapproved excipients, it struck me hard: these standards keep drugs safe. Not everyone pays attention to excipients, but as soon as an impurity scandal breaks, the spotlight gets intense. With pharma-grade lactose, there’s confidence in every batch analysis, whether it’s moisture content or solvent residues.

Daily Reality Inside the Lab

Not all lactose behaves the same way when mixed. Monohydrate versions tend to work better in wet granulation, and the anhydrous type supports direct compression. I've seen process lines jam because the wrong grade slipped through. Technicians ended up spending hours cleaning stuck machines. Lactose pharmacopeia grades guarantee certain physical characteristics so machines run smoothly and tablets feel right. The consistency these standards demand means the end-user—someone who needs their pain pill or allergy treatment—actually gets the dose listed on the box.

Patient Safety Is Not Negotiable

Patients with rare lactose intolerance feel wary about excipients, and pharmacists need clear labeling to advise them. Pharma-grade lactose comes with detailed certificates of analysis, so it’s possible to trace every delivery back to its origin. This might seem overly cautious, but when vulnerable people rely on medication, even milligram differences could be dangerous. In emergency care as well as routine pharmacy practice, these details can add up to big consequences.

Pushing for Continuous Improvement and Alternatives

Regulatory agencies and advocacy groups grow more interested in allergy-friendly medicines. While lactose BP EP USP often meets legal and safety demands, the industry keeps working on substitutes, such as plant-based fillers or modified starches. My conversations with fellow pharmacists and R&D chemists show appetite for innovation remains strong, though cost and regulatory hurdles slow adoption. Putting new excipients on the market requires heavy validation and studies, much more than the legacy ingredients. Lactose will likely stick around, but it should not stiff-arm new research.

Weighing Cost and Access

Practicality matters too. Pharma-grade lactose is accessible worldwide and affordable for nearly every manufacturer, which helps drive down medicine prices. By keeping this base ingredient reliable and low-cost, makers free up time and funds to focus on releasing new treatments or supporting more complex R&D. In my experience, these incremental savings matter more than people realize, especially in markets where patients pay out of pocket.

Moving Forward

Lactose BP EP USP pharma grade delivers trust, process efficiency, and safety in pharmaceutical settings. While no ingredient works perfectly for every case, sticking to robust grades and remaining open to better alternatives will keep both patients and the broader community safer.

What are the quality standards of Lactose BP EP USP Pharma Grade?

Why Quality in Lactose Matters

Big pharma and small-scale manufacturers both care about the powder that goes into pills. Anyone who’s ever swallowed a chalky tablet owes something to lactose. Lactose isn’t just a filler; for many medicines, it keeps the active ingredients stable and helps with proper tablet formation. If pharma companies ignore quality, risks start multiplying fast.

Growing up around pharmacists, I heard time and again how some simple ingredients could make or break a drug’s performance. Imagine a batch of painkillers that disintegrates too quickly or not at all. That kind of problem traces back to poor excipient quality—lactose sets the bar here.

Guidelines: BP, EP, and USP

Pharmaceutical lactose has to pass the British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) standards. Each group maintains strict guidelines. They check crystal structure, microbial content, chemical content, and pyrogen levels. There’s no mystery why. Milk sugar that carries any hint of contamination can cause reactions in sick or vulnerable patients.

According to USP, vendors supply lactose that stays under 0.5% moisture and almost no visible impurities. BP and EP agree. Their rules require a white, odorless, and slightly sweet powder that dissolves fully in water, confirms negative for heavy metals, and does not change color under their tests. Discoloration flags problems like overheating in processing, which can trigger unwanted chemical changes.

Digging Deep: Purity and Microbes

Lactose purity means more than just a clean white appearance. BP and EP laboratories screen for specific sugars—glucose, galactose, and sucrose get flagged if found in high amounts. On top of that, companies regularly run microbial tests. Pharmacopeia guidelines put upper limits on bacteria or mold. Any excipient that exceeds these levels flunks. Those checks matter, because poor control can lead to infection for patients who take medicines made from substandard sources.

I’ve watched local pharmacies recall entire shipments over minor contamination. Nothing upsets trust like discovering your medicine contains traces of E. coli. That’s real risk, not just a technicality.

Why Particle Size and Flow Rate Count

Lactose grains need a consistent size. Manufacturers go through great lengths to keep particle size distribution within a tight range. They use sieves, air-jet equipment, and laser analysis. If the powder contains too many fines or clumps, tablets can become brittle or fail the required weight checks. Consistent flow ensures pills come off the production line at speed and with solid reliability. Factories can't afford to halt production for poor lactose flow.

USP and EP both mandate tests for flow rate to avoid blockages or uneven mixing. This detail protects against costly manufacturing errors. Without these requirements, the industry would see more defective batches, or worse, medicine that loses potency.

Tougher Demands Mean Better Solutions

Meeting these standards isn’t simple. Dairy companies must invest in filtered air, aseptic handling, and high-capacity dryers. Regular audits—both announced and surprise—push them to keep quality high. Automation pairs with sharp-eyed technicians for routine batch checks.

To further lower risk, pharmaceutical firms are starting to partner directly with trusted lactose producers instead of open-market buying. Some advocate for blockchain tracing so anyone along the chain can track impurity levels and batch histories. The field keeps pushing for better, not just because of rules but because inside every tablet sits someone’s health.

Is Lactose BP EP USP Pharma Grade free from allergens and impurities?

Understanding Pharmaceutical-Grade Lactose

Pharmaceutical lactose lands in medicines for a simple reason: it works as a reliable filler in tablets and capsules. The terms “BP”, “EP”, and “USP” point to British, European, and United States Pharmacopeia standards. Drug makers trust these stamps when quality and consistency matter. Each batch undergoes lab tests, which look for things like purity, microbial counts, and certain contaminants. Pharmaceutical guidelines set strict levels for acceptable impurities, reaching down to parts per million.

Tracing Allergens Back to Dairy Origins

Milk acts as the main source for lactose production. Dairy allergies mostly trace back to milk proteins, like casein and whey, rather than lactose itself. Processing strips most of these proteins out, leaving the sugar behind. Despite rigorous purification, minute traces can remain. Some lab tests catch protein levels in the range of a few micrograms per gram, but zero protein is rarely guaranteed. Most folks with lactose intolerance handle pharma-grade lactose because the issue involves an enzyme, not the immune system. People living with severe milk protein allergies, though, could still face a risk, especially at sensitive thresholds.

The European Pharmacopeia sets a limit for proteins in lactose, currently less than 0.1%. That figure sounds tiny, but even that level isn’t “free from” in the true sense. U.S. standards stick close to these thresholds too; labs frequently run nitroprusside tests or use chromatography to make sure manufacturers keep protein contamination low. In the real world, I’ve seen companies pull lots off shelves because testing flagged trace proteins or dust contamination, usually because machines weren’t cleaned well between runs. Equipment sharing with other dairy-derived substances can invite trouble, too.

Pushing Toward Purity

Drug laws expect manufacturers to document every step that goes into making lactose. They require certificate of analysis papers for each batch before release. Regulators keep checking, and pharmaceutical companies implement audits and upward pressures on purity. Still, nothing guarantees a product ranks as “allergen-free”—especially for those dealing with severe dairy allergies.

A few drug makers have invested in newer purification tech, like ultrafiltration and advanced crystallization. These steps lower protein residue but boost costs. Full testing for all known milk allergens would slow operations even further. Ideally, clearer labeling and transparent certificates should become industry norms. Doctors, pharmacists, and patients thrive on knowing their risks.

Options for Sensitive Patients

The best path for people with severe allergies involves speaking with healthcare providers about their concerns. In my work with patients, I’ve seen success with compounded medications that leave out lactose entirely—using non-dairy fillers, sometimes synthetics or plant-based alternatives. Large-scale pharma brands could take a page from those playbooks, offering more allergy-safe versions, especially in pediatric and geriatric products.

Overall, pharma-grade lactose delivers remarkable purity and safety for most patients. Yet, the conversation around trace allergens remains important. Greater investment in technology, more precise testing, and patient-centered labeling would all bring safer outcomes for people who trust medication daily.

How should Lactose BP EP USP Pharma Grade be stored and handled?

Real-World Experience: Why Storage Matters

Most people familiar with pharmaceutical ingredients know mistakes during storage can ruin a whole batch and cost a company dearly. Lactose meant for pharma use comes with clear expectations about purity and performance, so no one cuts corners on keeping it safe from harm. I recall working on a project where moisture destroyed hundreds of kilos of chem-grade lactose—replacing it added months to the delivery schedule. That experience shaped how I handle every specialty powder since.

Keep It Cool and Dry

Lactose pulls water right out of the air. Let it sit in a humid warehouse, the powder turns clumpy, starts to cake, and nobody can rely on its weight for a clean tablet blend. Good practice means storing it in a cool, dry place—think between 15 and 25°C, not the sweltering end of the factory floor or a loading dock in summer. Humidity stays below 60%. In most places, that means using dehumidifiers or sealed climate control rooms. Don’t trust loose packaging; once moisture sneaks in, the ingredient turns unreliable.

Shielding from Light and Air

The longer lactose sits exposed, the greater the risk something goes wrong. Direct sunlight drives temperature up inside bags or boxes, even in shaded buildings. That extra heat can set off slow chemical changes, and you’ll never catch them until tablets go brittle or fail quality checks. Oxygen leaks into half-closed sacks, especially in big bulk warehouses, so standard operating procedure always keeps these powders sealed in original packaging until use.

Clean Handling Makes the Difference

It’s easy to get careless with white powders that look like ordinary sugar. During batch prep, all surfaces and equipment must be spotless. Even trace oils or powders from an earlier run could put a shipment out of spec. Personnel wear cleanroom suits, gloves, and hairnets, since sweat and skin cells bring in bacteria. Lactose doesn’t support much microbial growth, but pharma grade products get contaminated fast in a messy environment. One slip-up—the wrong scoop, the wrong transfer bin—and regulators start asking questions nobody wants to answer.

Testing and Traceability

Pharma companies track every bag from the mill to the pill press. Labels on containers give a full record—manufacturer, batch, manufacturing date, expiry, sampling record. Each transfer gets logged in case a recall ever comes up. I’ve seen companies insist on triple-checking the intact seal before opening; any damaged package never enters the cleanroom. That’s not overkill—regulatory files demand proof each ingredient stayed protected the whole journey.

The Bigger Picture: Training and Culture

Anyone in the pharma supply chain who doesn’t value these details risks turning high-purity lactose into useless powder. Training every worker—from warehouse to lab technician—creates a culture where people spot problems early. I’ve watched experienced operators spot condensation on a container and halt the whole shipment for inspection. That vigilance saves money, keeps batches reproducible, and defends a company’s reputation. Empirical controls aren’t always enough—people need to feel ownership of safety and quality.

Looking Ahead: Smarter Practices

Modern solutions now add data loggers to every pallet, tracking humidity and temperature in real-time on the blockchain. Managers get alerts if conditions shift, and the chain of custody stays transparent. But even the smartest tech cannot replace human attention and discipline. Storing and handling lactose pharma grade right means respecting its role as the backbone of essential medicines and taking every simple step seriously.

Lactose BP EP USP Pharma Grade
Names
Preferred IUPAC name β-D-galactopyranosyl-(1→4)-D-glucose
Other names Lactose Monohydrate
Pharma Grade Lactose
Lactose USP
Lactose EP
Lactose BP
Milk Sugar
Pronunciation /ˈlæk.təʊs biː piː iː piː juː ɛs piː ˈfɑː.mə ɡreɪd/
Identifiers
CAS Number 63-42-3
Beilstein Reference 1716012
ChEBI CHEBI:17716
ChEMBL CHEBI:17716
ChemSpider 3564165
DrugBank DB09438
ECHA InfoCard 18c3a4e9-cfe9-4ee2-b709-944c2c9e212e
EC Number 200-559-2
Gmelin Reference 51864
KEGG C00243
MeSH D-Lactose
PubChem CID 6134
RTECS number **OD9625000**
UNII J2B2A4N98G
UN number UN Number: Not regulated
CompTox Dashboard (EPA) CompTox Dashboard (EPA) of product 'Lactose BP EP USP Pharma Grade' is "DTXSID5044257
Properties
Chemical formula C12H22O11
Molar mass 342.30 g/mol
Appearance White or almost white, crystalline powder.
Odor Odorless
Density 0.85 g/cm³
Solubility in water Soluble in water
log P -5.2
Vapor pressure Negligible
Acidity (pKa) ~12.4
Basicity (pKb) pKb: 9.42
Magnetic susceptibility (χ) Diamagnetic
Refractive index (nD) 1.427
Viscosity Viscosity: 10 - 20 cP (10% solution at 20°C)
Dipole moment 0 D
Thermochemistry
Std molar entropy (S⦵298) 387.2 J·mol⁻¹·K⁻¹
Std enthalpy of combustion (ΔcH⦵298) -2815 kJ/mol
Pharmacology
ATC code A11HA31
Hazards
Main hazards May cause respiratory irritation.
GHS labelling GHS07, Warning, H315, H319, H335
Pictograms GHS07
Signal word Warning
Hazard statements Hazard statements: Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
Precautionary statements Precautionary statements: Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
NFPA 704 (fire diamond) Health: 1, Flammability: 1, Instability: 0, Special: -
Flash point > 210 °C
Autoignition temperature 400°C
LD50 (median dose) LD50 (oral, rat): > 10,000 mg/kg
PEL (Permissible) 10 mg/m3
REL (Recommended) 200-400 mg
IDLH (Immediate danger) No IDLH established.
Related compounds
Related compounds Cellobiose
Lactulose
Sucrose
Maltose
Glucose
Galactose
Dextrose
Trehalose